drugset / Trial / NCT06629116

Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After Thrombectomy

NCT06629116

Recruiting 100 enrolled Tingyu-Yi
RandomizedParallel-groupOpen-labelTreatment

Summary

This project intends to explore the therapeutic efficacy of human serum albumin in mitigating postoperative cerebral edema and enhancing clinical outcomes following mechanical thrombectomy in patients with acute anterior circulation large-core ischemic stroke.

Timeline

Start
2024-01-30
Primary completion
2026-12-30
Completion
2027-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Human serum albumin Protein / enzyme biologic 20 % Intravenous
Subject Human serum albumin Protein / enzyme biologic 100 ml Intravenous

Indications